CBD for sickle cell pain
Treatments studied
Part of Blood & lymphatic, Genetic & congenital, Pain clinical trials.
This trial tests if cannabidiol (CBD) can help reduce pain interference in adults with sickle cell disease. You will take CBD daily for 4 weeks and report your pain levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have sickle cell disease (any type: SS, SC, Sβ+ thalassemia, Sβ0 thalassemia, or other HbS variant).
- Pain has bothered you enough in the past week to score 60 or lower on a standard pain interference questionnaire.
- If you take sickle cell treatments (like hydroxyurea, transfusions, or others) or pain medicines, you have been on a stable dose for at least 3 months.
- You have not used any cannabis or cannabis products in the past 30 days and agree to avoid them during the study.
- You are not pregnant or nursing, and if you could become pregnant, you will use a reliable birth control method.
- You have no history of psychosis, schizophrenia, or active suicidal thoughts.
- Your liver function is normal (ALT not more than 3 times the upper limit).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests a cannabinoid medicine (dronabinol) to reduce inflammation and pain related to sickle cell disease. It may help you have less pain that interferes with daily life if you meet the study requirements and can safely avoid cannabis during the study.
This trial tests whether adding acupuncture to standard pain treatments can help manage pain in people with sickle cell disease. It involves brain scans, questionnaires, and acupuncture sessions to see if this approach reduces pain and improves quality of life.
This study looks at what causes pain in people with sickle cell disease. They hope to learn more about pain patterns to better help patients manage it.
This trial tests if an intravenous medication called L-citrulline can help treat pain crises in children and young adults with sickle cell disease. Participants receive either the study drug or a placebo while in the hospital for a severe pain episode.
This trial tests CS-206, an experimental therapy for people with sickle cell disease. It aims to reduce severe complications like pain crises, acute chest syndrome, strokes, and other serious events. You may qualify if you have a specific genetic type of sickle cell disease and have experienced complications despite standard treatments.
This study tests an oral medicine called rilzabrutinib to see if it can reduce painful episodes in people with sickle-cell disease. It may be an option if you have regular pain crises and are looking for a new treatment.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.